News

Fatty liver disease is becoming increasingly common, and many people are unaware that they have it. It often shows up during ...
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Discover How the Best Supplement for Fatty Liver Combines Milk Thistle, NAC, Choline & Turmeric to Support Liver Detox, Bile ...
Discover a study that showed that bariatric surgery increased survival in patients with cirrhosis compared to lifestyle ...
Weight-Loss Surgery Lowers Risk of Developing Complications of Liver Disease in Patients With Cirrhosis and Obesity Jan. 27, 2025 — A study shows that patients with obesity and fatty liver ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.
The company said that its test could overcome sensitivity issues with ultrasound and serum alpha-fetoprotein assays that are used to monitor at-risk patients.
White patients had an increased burden of advanced liver fibrosis vs Black patients, despite comparable levels of inflammation.